| |
Age group
|
|---|
|
Oxidative markers
|
35-49 years
|
> 50 years
|
|---|
| |
Placebo
|
TRF
|
Placebo
|
TRF
|
|---|
|
Protein carbonyl (nmol/mg)
| | | | |
|
Baseline (0 month)
|
0.54 ± 0.08
|
0.58 ± 0.08
|
0.50 ± 0.06
|
0.63 ± 0.03
|
|
3 months
|
0.56 ± 0.13
|
0.54 ± 0.05
|
0.48 ± 0.05
|
0.52 ± 0.06
|
|
6 months
|
0.60 ± 0.08
|
0.51 ± 0.06
|
0.47 ± 0.04
|
0.40 ± 0.03**
|
|
Advanced glycosylation end-product (units/ml)
| | | | |
|
Baseline (0 month)
|
2.39 ± 0.15
|
2.10 ± 0.22
|
2.34 ± 0.22
|
2.73 ± 0.26
|
|
3 months
|
2.01 ± 0.18
|
2.38 ± 0.21
|
2.30 ± 0.26
|
2.24 ± 0.35
|
|
6 months
|
2.12 ± 0.22
|
2.02 ± 0.17
|
1.98 ± 0.25
|
1.71 ± 0.24*
|
|
Malondialdehyde (nmol/ml)
| | | | |
|
Baseline (0 month)
|
4.25 ± 0.30
|
3.45 ± 0.37
|
4.18 ± 0.23
|
4.71 ± 0.41
|
|
3 months
|
4.82 ± 0.34
|
3.95 ± 0.39
|
3.22 ± 0.22
|
3.86 ± 0.34
|
|
6 months
|
3.95 ± 0.31
|
4.48 ± 0.27
|
3.87 ± 0.36
|
3.87 ± 0.32
|
- Values are expressed as mean ± SEM.
- Symbols indicate significant difference from baseline (0 month).
- *: p < 0.05, **: p < 0.001
